AMENDMENT NO. 4 TO THE PATENT LICENSE AGREEMENT NO. C-00061901
Exhibit 10.1.4
AMENDMENT NO. 4 TO THE PATENT LICENSE AGREEMENT NO. C-00061901
BETWEEN:
L’Institut Pasteur, a public interest foundation, 00, xxx xx Xxxxxxx Xxxx, 00000 Xxxxx, represented by Mr. Christophe Mauriet, Adjunct General Manager,
Hereafter referred to as “IP” or the “LICENSOR”, acting both on its own behalf and on behalf of:
| • | Université Pierre et Xxxxx Xxxxx, 0, xxxxx xx Xxxxxxx, 00000 Xxxxx Cedex 05, hereafter referred to as “UPMC”, |
| • | Institut Xxxxx, 00, xxx x’Xxx, 00000 Xxxxx cedex 05, hereafter referred to as “IC”, |
| • | Le Centre National de la Recherche Scientifique, 0, xxx Xxxxxx-Xxxx, 00000 Xxxxx Cedex 16, hereafter referred to as “CNRS”. |
Jointly also referred to as the “LICENSOR”,
Party of the first part,
AND:
CELLECTIS, a public limited company with a capital of 1,023,803.15 euros, headquartered at 0 Xxx xx xx Xxxxx Xxxxx, 00000 Xxxxx cedex 15, represented by Xx. Xxxxx Xxxxxxxx, acting as Chief Executive Officer
Hereafter referred to as “Cellectis” or the “Licensee”,
Party of the second part.
The LICENSOR and LICENSEE are hereafter referred to as the “Parties”.
RECITALS:
On June 19, 2000, the Parties signed the license agreement no. C-00061901, modified by amendment no. 1 on March 15, 2001, amendment 2 on September 8, 2003, amendment 3 on February 26, 2008, (hereafter the “AGREEMENT”) by which the LICENSOR grants the LICENSEE operating rights over certain patent families.
Following discussions and exchanges between the Parties, they have decided by mutual agreement to remove from the AGREEMENT the patent family based on priority application FR95/09587 filed on August 7, 1995 and awarded on October 10, 1997, titled “Insertion gene cellule eucaryote”.
The Parties agree by this Amendment no. 4 to modify Schedule A of the AGREEMENT and the definition of the “AGREEMENT PATENTS” stated in Article 1.2 of the AGREEMENT.
It is thus agreed as follows:
ARTICLE 1
The Parties agree that Schedule A of this Amendment no. 4 replaces Schedule A of the AGREEMENT.
The Parties agree that in this Amendment no. 4, French patent no. 9509587, awarded on October 10, 1997, is excluded from the definition of the “AGREEMENT PATENTS” stated in article 1.2 of the AGREEMENT.
The AGREEMENT PATENTS are hereby defined as follows:
| • | U.S. patent application Serial No. 07/879,689 filed on May 5, 1992 in the names of IP and UPMC, titled “Nucleotide sequence encoding the enzyme I-SceI and the uses thereof”, American patent no. 5830729 awarded on November 3, 1998, any divisional applications, “continuing” applications or reissue applications made on the basis of the patents and patent applications cited above, including the PCT extension of this application, published under no. WO 96 14 408, and patents and patent applications that may result from them, which are listed in Schedule A of this AGREEMENT, and the corresponding awarded patents which will be automatically added to SCHEDULE A of this AGREEMENT. |
| • | U.S. patent application Serial No. 634,192 filed on April 18, 1996 in the names of IP, IC and CNRS, which has never been extended abroad, and which gave rise to US patent no. 5 830 729 awarded on November 3, 1998, any divisional applications, “continuing” applications or re-issue applications filed on the basis of the patent application cited above, and |
| • | U.S. patent application no. US 275,638 filed on March 15, 2001 and titled “characterization of the I-SpomI Endonuclease from fission yeast”, including the PCT extension of this application, published under no. WO 02/074965, the patents and patent applications resulting from it, any patent application claiming priority over one of the aforementioned applications, any divisional applications, “continuing” applications or re-issue applications filed on the basis of the patents and patent applications cited above. |
ARTICLE 2
2.1 All other provisions of the AGREEMENT shall remain unchanged and fully applicable between the Parties.
2.2 This Amendment no. 4 enters into force on its date of signature by the Parties.
2.3 This Amendment no. 4 and its Schedule form an integral part of the AGREEMENT.
| Signed in Paris on | [Handwritten text: April 11, 2103] | |||
| In 2 original copies. | ||||
| CELLECTIS | INSTITUT PASTEUR |
SCHEDULE A
AGREEMENT PATENTS
| Country |
Title |
Filing Number |
Filing date |
Type |
Holder 1 |
Holder 2 |
Holder 3 |
Issuance |
Date | |||||||||
| CANADA | SYNTHETIC GENE CODING FOR I-SceI ENZYME… | CA2283569 | Nov. 6, 95 | Institut Pasteur | Université P.M. XXXXX | CNRS | ||||||||||||
| EUROPE | SYNTHETIC GENE CODING FOR I-SceI ENZYME… | EP959384181 | Nov. 6, 1995 | Institut Pasteur | Université P.M. XXXXX | CNRS | ||||||||||||
| JAPON | SYNTHETIC GENE CODING FOR I-SceI ENZYME… | JP51505896 | Nov. 6, 1995 | Institut Pasteur | Université P.M. XXXXX | CNRS | ||||||||||||
| United States | SYNTHETIC GENE CODING FOR I-SceI ENZYME… | US971160 | Nov. 5, 1992 | Continuation in part | Institut Pasteur | Université P.M. XXXXX | CNRS | 5474896 | Dec. 12, 95 | |||||||||
| United States | SYNTHETIC GENE CODING FOR I-SceI ENZYME… | US336241 | Nov. 7, 1994 | Continuation in part | Institut Pasteur | Université P.M. XXXXX | 5792632 | Nov. 8, 0000 | ||||||||||
| Xxxxxx Xxxxxx | SYNTHETIC GENE CODING FOR I-SceI ENZYME… | US417226 | April 5, 1995 | Division | Institut Pasteur | Université P.M. XXXXX | 5962327 | Oct. 5, 0000 | ||||||||||
| Xxxxxx Xxxxxx | SYNTHETIC GENE CODING FOR I-SceI ENZYME… | US465273 | June 5, 1995 | Continuation | Institut Pasteur | Université P.M. XXXXX | 5866361 | Feb 2, 0000 | ||||||||||
| Xxxxxx Xxxxxx | SYNTHETIC GENE CODING FOR I-SceI ENZYME… | US461624 | June 5, 1995 | Continuation | Institut Pasteur | Université P.M. XXXXX | ||||||||||||
| United States | SYNTHETIC GENE CODING FOR I-SceI ENZYME… | US643732 | June 5, 1996 | Continuation in part | Institut Pasteur | Université P.M. XXXXX | ||||||||||||
| United States | SYNTHETIC GENE CODING FOR I-SceI ENZYME… | US119024 | July 20, 1998 | Institut Pasteur | Université P.M. XXXXX | 5948678 | Sept. 7, 0000 | |||||||||||
| Xxxxxx Xxxxxx | SYNTHETIC GENE CODING FOR I-SceI ENZYME… | US196131 | Nov. 20, 1998 | Continuation | Institut Pasteur | Université P.M. XXXXX | ||||||||||||
| United States | SYNTHETIC GENE CODING FOR I-SceI ENZYME… | US244130 | Feb. 4, 1999 | Division | Institut Pasteur | Université P.M. XXXXX | ||||||||||||
| United States | SYNTHETIC GENE CODING FOR I-SceI ENZYME… | US492697 | Jan. 27, 2000 | Continuation | Institut Pasteur | Université P.M. XXXXX | ||||||||||||
| Country |
Title |
Filing Number |
Filing date |
Type |
Holder 1 |
Holder 2 |
Holder 3 |
Issuance |
Date | |||||||||
| United states | TRANSGENIC ANIMAL HOMOLOGOUS RECOMBINATION | US693948 | Aug. 7, 96 | Continuation | CNRS | Institut Pasteur | Institut Xxxxx | 5830729 | Nov. 3, 98 | |||||||||
| United states | TRANSGENIC ANIMAL HOMOLOGOUS RECOMBINATION | US116834 | July 17, 98 | Continuation | CNR | Institut Pasteur | Institut Xxxxx | |||||||||||
U.S. patent application no. US 275,638 filed on March 15, 2001 and titled “Characterization of the I-SpomI Endonuclease from fission yeast”, including the PCT extension of this application, published under no. WO 02/ 074965, the patent applications and patents resulting therefrom, any patent applications claiming priority over one of the aforementioned applications, any divisional applications, any continuing applications or any applications for re-issue filed on the basis of the aforementioned patents and patent applications.
